AR003476A1 - Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol - Google Patents

Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol

Info

Publication number
AR003476A1
AR003476A1 ARP960103957A AR10395796A AR003476A1 AR 003476 A1 AR003476 A1 AR 003476A1 AR P960103957 A ARP960103957 A AR P960103957A AR 10395796 A AR10395796 A AR 10395796A AR 003476 A1 AR003476 A1 AR 003476A1
Authority
AR
Argentina
Prior art keywords
tramadol
binder
salt
tablets containing
free tablets
Prior art date
Application number
ARP960103957A
Other languages
English (en)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR003476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR003476A1 publication Critical patent/AR003476A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se describen tabletas rápidamente disgregables y exentas de aglutinante que contienen tramadol o una sal de tramadol, para administración oral, y que secaracterizan por contener celulosa microcristalina.
ARP960103957A 1995-08-19 1996-08-12 Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol AR003476A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19530575A DE19530575A1 (de) 1995-08-19 1995-08-19 Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz

Publications (1)

Publication Number Publication Date
AR003476A1 true AR003476A1 (es) 1998-08-05

Family

ID=7769912

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103957A AR003476A1 (es) 1995-08-19 1996-08-12 Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol

Country Status (29)

Country Link
US (1) US5776492A (es)
EP (1) EP0759296B1 (es)
JP (1) JP4074675B2 (es)
CN (1) CN1102385C (es)
AR (1) AR003476A1 (es)
AT (1) ATE205708T1 (es)
AU (1) AU703310B2 (es)
BR (1) BR9604034A (es)
CA (1) CA2182939C (es)
CZ (1) CZ289167B6 (es)
DE (2) DE19530575A1 (es)
DK (1) DK0759296T3 (es)
ES (1) ES2164198T3 (es)
GR (1) GR3036720T3 (es)
HK (1) HK1010100A1 (es)
HU (1) HU227360B1 (es)
IL (1) IL119080A (es)
MY (1) MY113908A (es)
NO (1) NO313486B1 (es)
NZ (1) NZ299141A (es)
PE (1) PE8298A1 (es)
PL (1) PL184785B1 (es)
PT (1) PT759296E (es)
RU (1) RU2174837C2 (es)
SI (1) SI0759296T1 (es)
SK (1) SK281779B6 (es)
UA (1) UA41392C2 (es)
UY (1) UY24308A1 (es)
ZA (1) ZA966985B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389752C (zh) * 1978-04-21 2008-05-28 莱博法姆公司 控释组合物
US5989589A (en) * 1997-10-24 1999-11-23 Cartilier; Louis Cross-linked cellulose as a tablet excipient
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
ATE279186T1 (de) 1999-08-31 2004-10-15 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
DE19940944B4 (de) 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
ATE400819T1 (de) * 2002-10-25 2008-07-15 Labopharm Inc Zubereitungen mit kontrollierter freisetzung
AR045972A1 (es) * 2002-10-25 2005-11-23 Labopharm Inc Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas
CN1942175B (zh) * 2002-10-25 2010-05-26 莱博法姆公司 24小时有效的曲马多缓释制剂
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
DK1663182T4 (da) 2003-09-12 2020-02-17 Amgen Inc Hurtigt opløsende formulering af cinacalcet HCI
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
ITMI20130210A1 (it) 2013-02-14 2014-08-15 Menarini Lab Composizioni farmaceutiche contenenti dexketoprofene e tramadolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3181998A (en) 1960-08-12 1965-05-04 Joseph L Kanig Tablet disintegration
DE1617343B2 (de) 1967-04-21 1976-04-22 CH. Boehringer Sohn, 6507 Ingelheim Traegermasse fuer arzneimitteltabletten
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4600579A (en) 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
WO1987001936A1 (en) 1985-09-25 1987-04-09 Gerhard Gergely Desintegration tablet and process for its manufacture
CH675537A5 (es) 1988-03-25 1990-10-15 Ciba Geigy Ag
US5211957A (en) * 1988-03-25 1993-05-18 Ciba-Geigy Corporation Solid rapidly disintegrating dosage form
US5254355A (en) 1992-05-29 1993-10-19 Kraft General Foods, Inc. Process for beverage tablets and products therefrom
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung

Also Published As

Publication number Publication date
HU9602266D0 (en) 1996-10-28
SI0759296T1 (es) 2001-12-31
CN1145780A (zh) 1997-03-26
PL184785B1 (pl) 2002-12-31
DE59607710D1 (de) 2001-10-25
IL119080A0 (en) 1996-11-14
PT759296E (pt) 2002-03-28
CZ289167B6 (cs) 2001-11-14
NO313486B1 (no) 2002-10-14
IL119080A (en) 2001-07-24
NZ299141A (en) 1997-12-19
CN1102385C (zh) 2003-03-05
MY113908A (en) 2002-06-30
PE8298A1 (es) 1998-03-28
HUP9602266A3 (en) 1998-10-28
CA2182939C (en) 2007-06-19
ZA966985B (en) 1997-02-24
AU6194196A (en) 1997-02-27
HUP9602266A2 (en) 1997-12-29
CZ235996A3 (en) 1997-02-12
ES2164198T3 (es) 2002-02-16
JP4074675B2 (ja) 2008-04-09
SK281779B6 (sk) 2001-07-10
JPH09110684A (ja) 1997-04-28
GR3036720T3 (en) 2001-12-31
US5776492A (en) 1998-07-07
RU2174837C2 (ru) 2001-10-20
PL315749A1 (en) 1997-03-03
EP0759296B1 (de) 2001-09-19
HU227360B1 (en) 2011-04-28
UY24308A1 (es) 1996-08-27
EP0759296A1 (de) 1997-02-26
NO963430D0 (no) 1996-08-16
AU703310B2 (en) 1999-03-25
DE19530575A1 (de) 1997-02-20
SK104296A3 (en) 1997-05-07
CA2182939A1 (en) 1997-02-20
MX9603140A (es) 1997-07-31
HK1010100A1 (en) 1999-06-11
UA41392C2 (uk) 2001-09-17
DK0759296T3 (da) 2001-11-26
BR9604034A (pt) 1998-06-09
ATE205708T1 (de) 2001-10-15
NO963430L (no) 1997-02-20

Similar Documents

Publication Publication Date Title
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
ECSP034436A (es) Sales de valsartan
ES2159591T3 (es) Composicion de liberacion controlada.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
ES533580A0 (es) Un metodo para preaparar una composicion farmaceutica para aplicacion topica que contiene n-(2 hidroxietil)-pirrolidona.
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
UY24436A1 (es) Formulaciones orales de paroxetina de liberación controlada y retardada
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
PT839041E (pt) Sais de derivados de amidina e de inibidor de ciclooxigenase processo para a sua preparacao sua utilizacao como farmacos e composicoes farmaceuticas contendo os referidos sais
SE9700885D0 (sv) New pharmaceutical formulation
FI970058A0 (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
CA2203310A1 (fr) Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale
MA26899A1 (fr) PREPARATIONS CONTENANT UN MEDICAMENT GLUCOCORTICOiDE POUR LE TRAITEMENT DES MALADIES BRONCHOPULMONAIRES.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
NO963796D0 (no) Retard-tablett inneholdende Diclofenac-Na
DK0748222T3 (da) Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
NO975790L (no) Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer
ECSP961847A (es) Tabletas excentas de aglutinante que contienen tramadol o una sal de tramadol
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.

Legal Events

Date Code Title Description
FC Refusal